Aadi Bioscience, Inc. (AADI) Misses Q2 EPS by 12c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.87), $0.12 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Verizon to cut 3,000 jobs as it shifts stores to franchises
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
• F.N.B. Corp (FNB) Reports In-Line Q2 EPS